Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Homologous and heterologous booster vaccinations of S-268019-b, a recombinant S protein-based vaccine with a squalene-based adjuvant, enhance neutralization breadth against SARS-CoV-2 Omicron subvariants in cynomolgus macaques.
Hashimoto M, Aoe S, Kawazu Y, Seki NM, Hashimoto K, Yoshihara K, Homma T, Sonoyama T, Omoto S. Hashimoto M, et al. Among authors: seki nm. Vaccine. 2022 Dec 12;40(52):7520-7525. doi: 10.1016/j.vaccine.2022.10.092. Epub 2022 Nov 8. Vaccine. 2022. PMID: 36372670 Free PMC article.
Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Homma T, Nagata N, Hashimoto M, Iwata-Yoshikawa N, Seki NM, Shiwa-Sudo N, Ainai A, Dohi K, Nikaido E, Mukai A, Ukai Y, Nakagawa T, Shimo Y, Maeda H, Shirai S, Aoki M, Sonoyama T, Sato M, Fumoto M, Nagira M, Nakata F, Hashiguchi T, Suzuki T, Omoto S, Hasegawa H. Homma T, et al. Among authors: seki nm. Sci Rep. 2022 Dec 2;12(1):20861. doi: 10.1038/s41598-022-25418-5. Sci Rep. 2022. PMID: 36460696 Free PMC article.
Author Correction: Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice.
Homma T, Nagata N, Hashimoto M, Iwata-Yoshikawa N, Seki NM, Shiwa-Sudo N, Ainai A, Dohi K, Nikaido E, Mukai A, Ukai Y, Nakagawa T, Shimo Y, Maeda H, Shirai S, Aoki M, Sonoyama T, Sato M, Fumoto M, Nagira M, Nakata F, Hashiguchi T, Suzuki T, Omoto S, Hasegawa H. Homma T, et al. Among authors: seki nm. Sci Rep. 2024 Jan 31;14(1):2599. doi: 10.1038/s41598-024-52772-3. Sci Rep. 2024. PMID: 38297027 Free PMC article. No abstract available.
Transmission of COVID-19 in Nightlife, Household, and Health Care Settings in Tokyo, Japan, in 2020.
Imamura T, Watanabe A, Serizawa Y, Nakashita M, Saito M, Okada M, Ogawa A, Tabei Y, Soumura Y, Nadaoka Y, Nakatsubo N, Chiba T, Sadamasu K, Yoshimura K, Noda Y, Iwashita Y, Ishimaru Y, Seki N, Otani K, Imamura T, Griffith MM, DeToy K, Suzuki M, Yoshida M, Tanaka A, Yauchi M, Shimada T, Oshitani H. Imamura T, et al. JAMA Netw Open. 2023 Feb 1;6(2):e230589. doi: 10.1001/jamanetworkopen.2023.0589. JAMA Netw Open. 2023. PMID: 36826818 Free PMC article.
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study.
Shinkai M, Sonoyama T, Kamitani A, Shibata RY, Seki NM, Omoto S, Shinoda M, Sato T, Ishii N, Igarashi K, Ariyasu M. Shinkai M, et al. Among authors: seki nm. Vaccine. 2022 Jul 30;40(32):4328-4333. doi: 10.1016/j.vaccine.2022.06.032. Epub 2022 Jun 21. Vaccine. 2022. PMID: 35738968 Free PMC article. Clinical Trial.
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys.
Hashimoto M, Nagata N, Homma T, Maeda H, Dohi K, Seki NM, Yoshihara K, Iwata-Yoshikawa N, Shiwa-Sudo N, Sakai Y, Shirakura M, Kishida N, Arita T, Suzuki Y, Watanabe S, Asanuma H, Sonoyama T, Suzuki T, Omoto S, Hasegawa H. Hashimoto M, et al. Among authors: seki nm. Vaccine. 2022 Jul 29;40(31):4231-4241. doi: 10.1016/j.vaccine.2022.05.081. Epub 2022 Jun 6. Vaccine. 2022. PMID: 35691872 Free PMC article.
Hamster PIWI proteins bind to piRNAs with stage-specific size variations during oocyte maturation.
Ishino K, Hasuwa H, Yoshimura J, Iwasaki YW, Nishihara H, Seki NM, Hirano T, Tsuchiya M, Ishizaki H, Masuda H, Kuramoto T, Saito K, Sakakibara Y, Toyoda A, Itoh T, Siomi MC, Morishita S, Siomi H. Ishino K, et al. Among authors: seki nm. Nucleic Acids Res. 2021 Mar 18;49(5):2700-2720. doi: 10.1093/nar/gkab059. Nucleic Acids Res. 2021. PMID: 33590099 Free PMC article.